Total Payments
$130,932
2024 Payments
$17,189
Companies
20
Transactions
299
Medicare Patients
1,455
Medicare Billing
$262,790
Payment Breakdown by Category
Other$69,587 (53.1%)
Consulting$46,003 (35.1%)
Travel$8,312 (6.3%)
Food & Beverage$6,941 (5.3%)
Education$88.99 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $68,588 | 35 | 52.4% |
| Consulting Fee | $46,003 | 14 | 35.1% |
| Travel and Lodging | $8,312 | 44 | 6.3% |
| Food and Beverage | $6,941 | 204 | 5.3% |
| Grant | $1,000 | 1 | 0.8% |
| Education | $88.99 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $66,569 | 117 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $28,581 | 35 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20,241 | 38 | $0 (2020) |
| Genentech USA, Inc. | $9,500 | 24 | $0 (2019) |
| Merck Sharp & Dohme LLC | $3,107 | 7 | $0 (2024) |
| Genentech, Inc. | $1,000 | 1 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $523.27 | 26 | $0 (2024) |
| Gilead Sciences, Inc. | $408.41 | 23 | $0 (2021) |
| Eagle Pharmaceuticals, Inc. | $337.50 | 1 | $0 (2019) |
| Insmed, Inc. | $264.97 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,189 | 32 | United Therapeutics Corporation ($16,921) |
| 2023 | $27,063 | 37 | United Therapeutics Corporation ($22,939) |
| 2022 | $11,161 | 26 | United Therapeutics Corporation ($7,815) |
| 2021 | $17,252 | 27 | Actelion Pharmaceuticals US, Inc. ($8,975) |
| 2020 | $25,007 | 33 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13,113) |
| 2019 | $22,935 | 66 | Actelion Pharmaceuticals US, Inc. ($7,861) |
| 2018 | $3,015 | 47 | Genentech USA, Inc. ($1,822) |
| 2017 | $7,311 | 31 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,880) |
All Payment Transactions
299 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Cardio-pulmonary | ||||||
| 10/23/2024 | United Therapeutics Corporation | ORENITRAM (Drug), REMODULIN | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 09/25/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Respiratory | ||||||
| 08/16/2024 | United Therapeutics Corporation | TYVASO (Drug), REMODULIN | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 08/16/2024 | United Therapeutics Corporation | ORENITRAM (Drug), TYVASO, REMODULIN | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 08/15/2024 | United Therapeutics Corporation | TYVASO (Drug), REMODULIN, ORENITRAM | Food and Beverage | In-kind items and services | $111.51 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 08/15/2024 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $38.45 | General |
| 07/22/2024 | United Therapeutics Corporation | TYVASO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,270.00 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 07/08/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: Cardiology | ||||||
| 06/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $88.99 | General |
| Category: Cardiology | ||||||
| 06/06/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $114.40 | General |
| 05/30/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,270.00 | General |
| 05/13/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $16.58 | General |
| 05/08/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,840.00 | General |
| 04/26/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| 04/26/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| 04/23/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $28.80 | General |
| 04/22/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,270.00 | General |
| 04/20/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $64.26 | General |
| 04/20/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $64.26 | General |
| 04/20/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $64.25 | General |
| 04/18/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $114.40 | General |
| 04/15/2024 | United Therapeutics Corporation | TYVASO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,885.00 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 518 | 770 | $207,362 | $62,314 |
| 2022 | 6 | 350 | 786 | $236,685 | $72,808 |
| 2021 | 5 | 249 | 592 | $206,092 | $64,942 |
| 2020 | 5 | 338 | 621 | $202,397 | $62,725 |
Total Patients
1,455
Total Services
2,769
Medicare Billing
$262,790
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 71 | 217 | $58,957 | $22,580 | 38.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 79 | 136 | $52,836 | $16,315 | 30.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 13 | 26 | $19,779 | $4,880 | 24.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 24 | $12,701 | $3,524 | 27.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 47 | $8,883 | $3,149 | 35.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 27 | $9,696 | $3,108 | 32.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 18 | 18 | $9,979 | $2,888 | 28.9% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 128 | 141 | $13,114 | $2,657 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 18 | $5,198 | $1,379 | 26.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 13 | 15 | $13,966 | $1,177 | 8.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 95 | 101 | $2,253 | $654.87 | 29.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 111 | 407 | $105,311 | $36,302 | 34.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 91 | $65,930 | $17,249 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 85 | 155 | $42,625 | $12,168 | 28.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 35 | $17,640 | $5,830 | 33.0% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 46 | 46 | $4,075 | $888.72 | 21.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 47 | 52 | $1,105 | $370.77 | 33.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 32 | 121 | $84,272 | $24,021 | 28.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 74 | 244 | $61,809 | $22,520 | 36.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 95 | 176 | $48,154 | $14,488 | 30.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 18 | $8,934 | $3,268 | 36.6% |
| 94618 | Test for exercise-induced lung stress | Facility | 2021 | 32 | 33 | $2,923 | $644.25 | 22.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 57 | 148 | $98,716 | $30,016 | 30.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 82 | 237 | $58,302 | $21,734 | 37.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 80 | 115 | $30,245 | $7,336 | 24.3% |
About Dr. Christopher King, MD
Dr. Christopher King, MD is a Internal Medicine healthcare provider based in Falls Church, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700874948.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher King, MD has received a total of $130,932 in payments from pharmaceutical and medical device companies, with $17,189 received in 2024. These payments were reported across 299 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($68,588).
As a Medicare-enrolled provider, King has provided services to 1,455 Medicare beneficiaries, totaling 2,769 services with total Medicare billing of $262,790. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Falls Church, VA
- Active Since 10/12/2005
- Last Updated 05/23/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1700874948
Products in Payments
- UPTRAVI (Drug) $16,288
- OFEV (Drug) $14,336
- TYVASO (Drug) $11,370
- Esbriet (Biological) $9,479
- ORENITRAM (Drug) $7,507
- OPSUMIT (Drug) $4,245
- Adempas (Drug) $523.27
- Arikayce (Drug) $264.97
- OFIRMEV (Drug) $120.00
- Resolute (Device) $59.40
- REMODULIN (Drug) $52.71
- OPSUMIT MACITENTAN (Drug) $44.66
- ZENPEP (Drug) $36.45
- CoreValve Evolut (Device) $35.40
- VELETRI EPOPROSTENOL (Drug) $34.74
- GLASSIA (Biological) $25.47
- Xolair (Biological) $21.66
- XARELTO (Drug) $19.73
- The MetaNeb System (Device) $18.34
- Veltassa (Drug) $17.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Falls Church
Steven Nathan, Md, MD
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Amit Mahajan, M.d, M.D
Internal Medicine — Payments: $796,635
Internal Medicine $796,635
Dr. Kevin Donohue, D.o, D.O
Internal Medicine — Payments: $726,727
Internal Medicine $726,727
Sami Abdul Jawad, M.d, M.D
Internal Medicine — Payments: $212,772
Internal Medicine $212,772
Jeanny Aragon-Ching, M.d, M.D
Internal Medicine — Payments: $204,935
Internal Medicine $204,935
Joseph Krepp, M.d, M.D
Internal Medicine — Payments: $74,286
Internal Medicine $74,286